PT-141
Bremelanotide - melanocortin receptor agonist · Cognitive / Neuro Research
Cyclic melanocortin heptapeptide studied via central pathways.
PT-141 (bremelanotide) is a cyclic seven-residue melanocortin analog derived from alpha-MSH. Research interest centres on its central, receptor-mediated mechanism, which is distinct from the peripheral vascular pathways studied for other compounds. Research use only.
Available sizes: 10mg · Form: Lyophilized powder
Every lot ships with an independent third-party Certificate of Analysis - see the linked report for measured values.
How it is studied
- MC4R activation (Melanocortin) - Agonism at melanocortin-4 receptors is the primary mechanism studied in CNS models.
- Hypothalamic signaling (Neuro) - Investigated for modulation of hypothalamic circuits rather than peripheral vasculature.
- Cyclic MSH derivative (Structure) - The cyclised backbone confers stability relative to linear alpha-MSH fragments.
Research Use Only. Not for human or veterinary use.